Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Homology Medicines, Inc.    FIXX

HOMOLOGY MEDICINES, INC.

(FIXX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/25/2020 11/27/2020 11/30/2020 12/01/2020 12/02/2020 Date
9.6(c) 9.77(c) 9.84(c) 9.82(c) 9.77 Last
254 983 245 756 383 907 332 646 209 321 Volume
0.00% +1.77% +0.72% -0.20% -0.51% Change
More quotes
Financials (USD)
Sales 2020 2,38 M - -
Net income 2020 -131 M - -
Net Debt 2020 - - -
P/E ratio 2020 -3,43x
Yield 2020 -
Sales 2021 2,83 M - -
Net income 2021 -149 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,49x
Yield 2021 -
Capitalization 494 M 494 M -
Capi. / Sales 2020 207x
Capi. / Sales 2021 174x
Nbr of Employees 206
Free-Float 83,5%
More Financials
Company
Homology Medicines, Inc. is a genetic medicines company translating gene editing and gene therapy technology into treatments for patients with rare diseases. The Company is focused on developing a pipeline of new medicines that address and cure the underlying cause of monogenic diseases in the liver, central nervous system (CNS), bone marrow, lung and the eye. The Company’s lead product candidate, HMI-102 is a... 
More about the company
Notations Surperformance© of Homology Medicines, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about HOMOLOGY MEDICINES, INC.
11/26HOMOLOGY MEDICINES : pheNIX Data Presentation
PU
11/09HOMOLOGY MEDICINES : 3Q Earnings Snapshot
AQ
11/09HOMOLOGY MEDICINES : Reports Third Quarter 2020 Financial Results and Recent Hig..
AQ
11/09HOMOLOGY MEDICINES : Management's Discussion and Analysis of Financial Condition..
AQ
11/09Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Hi..
GL
11/09HOMOLOGY MEDICINES : Shares Rise 8% on $60 Million Pfizer Investment
DJ
11/09PFIZER : Makes $60 Million Equity Investment in Homology Medicines
DJ
11/09HOMOLOGY MEDICINES, INC. : Entry into a Material Definitive Agreement, Results o..
AQ
11/09PFIZER : Homology Medicines Announces $60 Million Equity Investment from Pfizer ..
AQ
11/09Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.
GL
11/06HOMOLOGY MEDICINES : Announces Presentation of Positive Data from the Dose-Escal..
AQ
11/06Homology Medicines Announces Presentation of Positive Data from the Dose-Esca..
GL
11/05HOMOLOGY MEDICINES : Announces Upcoming Oral Presentation on pheNIX Gene Therapy..
AQ
11/05Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therap..
GL
10/22HOMOLOGY MEDICINES : Unveils New In Vivo Gene Therapy Development Program for Hu..
AQ
More news
News in other languages on HOMOLOGY MEDICINES, INC.

- No features available -

More news
Chart HOMOLOGY MEDICINES, INC.
Duration : Period :
Homology Medicines, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HOMOLOGY MEDICINES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 28,88 $
Last Close Price 9,82 $
Spread / Highest target 277%
Spread / Average Target 194%
Spread / Lowest Target 52,7%
EPS Revisions
Managers
NameTitle
Arthur O. Tzianabos President, Chief Executive Officer & Director
Kush M. Parmar Chairman
W. Bradford Smith Chief Financial Officer, Secretary & Treasurer
Albert Seymour Chief Scientific Officer
Timothy P. Kelly Chief Technical Operations Officer
Sector and Competitors
1st jan.Capitalization (M$)
HOMOLOGY MEDICINES, INC.-52.56%494
GILEAD SCIENCES, INC.-5.94%76 616
VERTEX PHARMACEUTICALS5.18%59 887
REGENERON PHARMACEUTICALS36.91%54 257
WUXI APPTEC CO., LTD.64.86%39 976
BIONTECH SE236.51%27 452